The vaccine , known as RTS , S , took 30 years to develop but it is hoped it can be used to save millions of cases .
Researchers say the vaccine could make a ` substantial contribution ' to controlling the disease .
Drug firm GlaxoSmithKline has applied for a licence from the European Medicines Agency for the RTS vaccine , vaccine .
Tests were carried out on 15,500 toddlers and babies in sub-Saharan Africa .